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اإلضافة للسيستني يعيد تنشيط أنزمي کولينسرتاز البشري اليت يثبطها مبيد 
احلشرات العضوية الفوسفاتية الديكلوروفوس
حميد ر�سا حممدى، جعفر جليليان، حممد يحيى كرميي، �سيد �ستاب بو�سهرى
abstract: Objectives: Organophosphate (OP) pesticides inhibit both red blood cell (RBC) and plasma cholin-
esterases (ChEs). Oximes, especially pralidoxime (2-PAM), are widely used as antidotes to treat OP poisoning. In 
addition, N-acetylcysteine (NAC) is sometimes used as an adjuvant antidote. The current study aimed to assess 
the feasibility of using NAC as a single therapeutic agent for OP poisoning in comparison to in vitro 2-PAM. 
Methods: This study was carried out at the Razi Drug Research Center of Iran University of Medical Sciences, Tehran, 
Iran, between April and September 2014. A total of 22 healthy human subjects were recruited and 8 mL citrated 
blood samples were drawn from each subject. Dichlorvos-inhibited blood samples were separately exposed to low 
and high doses (final concentrations of 300 and 600 μmol.L-1, respectively) of 2-PAM, NAC and cysteine. Plasma and 
RBCs were then separated by centrifugation and their ChE activity was measured using spectrophotometry. 
Results: Although cysteine—and not NAC—increased the ChE activity of both plasma and RBCs over those of 
dichlorvos, it did not increase them over those of a high dose of 2-PAM. Conclusion: These results suggest that the 
direct reactions of 2-PAM and cysteine with dichlorvos and the reactivation of phosphorylated ChEs occurr via an 
associative stepwise addition-elimination process. High therapeutic blood concentrations of cysteine are needed 
for the elevation of ChE activity in plasma and RBCs; however, both this agent and NAC may still be effective in the 
reactivation of plasma and RBC ChEs.
Keywords: Organophosphate Poisoning; Antidotes; Cysteine; N-Acetylcysteine; Pralidoxime Compounds; Cholin-
esterases.
امللخ�ص: الهدف: مبيدات الفو�سفات الع�سوي هي مواد من �سنع االإن�سان وهي تثبط انزمي الكولين�سرتاز يف كل من خاليا الدم احلمراء )كرات 
الفو�سفات  الت�سمم مببيدات  لعالج  �سائعة، كرتياق  ب�سورة  الرباليدوك�سيم  و خ�سو�سا  االأوك�سيمات،  وت�ستخدم  البالزما.  و  احلمراء(  الدم 
الع�سوي. وباالأ�سافة ايل ذلك فقد ت�ستخدم مادة ال ن-اأ�سيتيل �سي�ستني يف بع�ص االأحيان كرتياق م�ساعد. هدفت هذه الدرا�سة اأيل تقييم 
جدوى اأ�ستخدام مادة ال ن-اأ�سيتيل �سي�ستني كعامل عالجي احدي للت�سمم مببيدات الفو�سفات الع�سوي ومقارنتها مع مادة الرباليدوك�سيم 
يف املخترب. الطريقة: اأجريت هذه الدرا�سة يف مركز الرازي لبحوث املخدرات، جامعة ايران للعلوم الطبية، طهران، اإيران، بني اأبريل و�سبتمرب 
2014. يف هذه الدرا�سة مت �سحب ثمانية ميلى ليرت عينات دم معالج مبادة ال�سيرتات من 22 �سخ�سا �سليما. مت تعري�ص عينات الدم املثبطة 
مبادة الديكلوروفو�ص ب�سكل منف�سل جلرعات منخف�سة ثم مرتفعة من الرباليدوك�سيم و ال ن-اأ�سيتيل �سي�ستني وال�سي�ستني )برتكيزات نهائية 
مقدارها 300 ميكروموالر 600 ميكروموالر علي التوايل(. بعد ذلك مت ف�سل البالزما وكرات الدم احلمراء من العينات بوا�سطة الطرد املركزي 
تالها القيا�ص الطيفي لن�ساط اأنزمي الكولين�سرتاز بهم. النتائج: اأظهرت النتائج اأنه على الرغم من ال�سي�ستني )ولي�ص ال ن-اأ�سيتيل �سي�ستني ( 
اأدى ايل زيادة كبرية يف ن�ساط انزمي الكولين�سرتاز يف كل من البالزما وكرات الدم احلمراء تغلبت على تثبيط مادة الديكلوروفو�ص، ولكنها 
لي�ست بنف�ص الن�سبة التي حتدثها تلك اجلرعة العالية من الرباليدوك�سيم. اخلال�صة: ت�سري نتائج الدرا�سة احلالية ايل اأن التفاعالت املبا�رصة 
بني كل من الرباليدوك�سيم وال�سي�ستني مع مادة الديكلوروفو�ص توؤدي اأيل تن�سيط انزمي الكولين�سرتاز املف�سفر، بطريقة ت�ساعدية تعتمد على 
االأ�سافة واحلذف. وبالرغم من احلاجة اأيل وجود تركيزات عالية من ال�سي�ستني يف الدم لكي تزيد من ن�ساط انزمي الكولين�سرتاز اال ان هذه 
املاده ومادة ال ن-اأ�سيتيل �سي�ستني قد يكون لهما دور فعال يف اعادة تن�سيط انزمي الكولين�سرتاز يف كل من البالزما وكرات الدم احلمراء.
الكلمات املفتاحية: الت�سمم مبركبات الفو�سفات الع�سوي؛ ترياق؛ ال�سي�ستني؛ ن-اأ�سيتيل �سي�ستني؛ مركبات الرباليدوك�سيم؛ انزمي الكولين�سرتاز.
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Advances in Knowledge
- The results of the present study showed that, although high concentrations of cysteine increased dichlorvos-inhibited acetyl- and 
pseudocholinesterase activities, this agent was less efficient than pralidoxime in the reactivation of human cholinesterases.
- In addition, the study illustrated that cysteine directly reacts with and inactivates dichlorvos at low plasma concentrations, while it 
replaces serine in the dichlorvos-cholinesterase complex at a very high plasma concentration and regenerates inhibited cholinesterases 
as well as having a direct reaction with dichlorvos. 
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Organophosphate (op) pesticides are man- made phosphoric acid esters that inhibit and inactivate both true (i.e. acetylcholin- 
esterase [AChE]) and pseudo- (i.e. butyrylcholinesterase 
[BuChE]) cholinesterases (ChEs) by a nucleophilic 
reaction in which the associative two-step addition-
elimination reaction with the serine hydroxyl group 
at their active sites results in phosphorylated and 
inactivated enzymes.1,2 AChE is primarily found in 
nervous tissue and erythrocytes; erythrocytic ChE 
activity more accurately reflects nervous tissue AChE 
activity than BuChE, which is primarily produced 
in the liver and appears in plasma, with its activity 
varying with a number of disorders including liver 
disease.3,4 The irreversible inactivation of ChEs by 
the dealkylation of the OP moiety of the OP-ChE 
complex is known as ageing, in which the phosphorus-
oxygen bond of the OP-ChE complex strengthens.5 
After ageing occurs, even oximes are ineffective 
in reactivating the enzyme, and the only means of 
restoring ChE activity is via the lengthy process of 
synthesizing a new AChE enzyme.2
At present, two main antidotes exist for the 
treatment of OP poisoning: atropine and oximes, 
particularly pralidoxime (2-PAM) in the latter 
group.2 However, oximes are not always useful in 
the management of OP poisoning.6–8 Moreover, the 
phosphorylated oxime complex is a strong inhibitor 
of ChEs and oximes themselves can inhibit AChEs.9 
Thus, the introduction of new, more efficient and 
less toxic antidotes to OP poisoning seems necessary. 
N-acetylcysteine (NAC) is a prodrug of cysteine and 
a mucolytic agent with potent antioxidant and free 
radical scavenging properties; it is currently used to 
treat acetaminophen poisoning and as an adjuvant 
antidote for OP poisoning.10,11 Other medical uses 
of NAC include the treatment of radiocontrast-
induced nephropathy, cyclophosphamide-induced 
haemorrhagic cystitis and a number of psychiatric 
disorders.12–14 Furthermore, NAC has significant anti- 
viral activity against the influenza A viruses.15 The 
present study aimed to assess the feasibility of cysteine 
administration as a single therapeutic agent for the 
reactivation of both AChE and BuChE in comparison 
with in vitro 2-PAM administration.
Methods 
This study was carried out at the Razi Drug Research 
Center, Iran University of Medical Sciences, Tehran, 
Iran, between April and September 2014. A total of 22 
healthy human subjects were recruited to participate 
in the study. Each participant was requested to 
complete a questionnaire to determine their health 
status, use of medications, occupational history and 
exposure to pesticides. Subjects with a history of 
diabetes mellitus, hypertension, liver disease, anaemia, 
malnutrition, cancer or other chronic illnesses and 
those who smoked cigarettes, used alcohol or drugs 
or had a history of radiotherapy were excluded from 
the study. 
The following chemicals and solutions were 
purchased: 5,5'-Dithiobis(2-nitrobenzoic acid) (DTNB), 
N-acetylcysteine, cysteine, potassium dihydrogen 
phosphate, dipotassium hydrogen phosphate, sodium 
chloride and tripotassium citrate monohydrate (Merck 
KGaA, Darmstadt, Germany); quinidine sulfate 
dihydrate, acetylthiocholine iodide and S-butyryl-
thiocholine iodide (Sigma-Aldrich Corp., St. Louis, 
Missouri, USA); dichlorvos of 98% weight/weight 
purity (Gyah Corp., Karaj, Iran); and 2-PAM methyl-
sulfate (Laboratoires SERB, Paris, France). Stock 
solutions of dichlorvos, 2-PAM, NAC and L-cysteine 
were each separately prepared in a 0.9% weight/volume 
(w/v) solution of sodium chloride in distilled water (i.e. 
normal saline) to produce final concentrations of 
21.0 μg.mL-1 (95 μmol.L-1), 14.9 mg.mL-1 (60 mmol.L-1), 
9.80 mg.mL-1 (60 mmol.L-1) and 7.27 mg.mL-1 
(60 mmol.L-1). All stock solutions were stored in the 
dark at 4 °C.
An 8-mL blood sample was obtained from 
each subject and immediately citrated with a 3.8% 
w/v tripotassium citrate solution to prevent clot 
formation.16 Each sample was then divided into 1 mL 
aliquots. The first aliquot was considered as a control 
and placed in a water bath at 37 °C for 80 minutes. The 
second aliquot was exposed to dichlorvos at a final 
concentration of 0.95 μmol.L-1 in a 37 °C water bath 
for 80 minutes.17 The remaining aliquots were exposed 
to dichlorvos at a final concentration of 0.95 μmol.L-1 
in a water bath at 37 °C for 20 minutes, followed by 
- These findings indicate that the effectiveness of cysteine in dichlorvos-induced poisoning depends on both dichlorvos and cysteine plasma 
concentrations.
Application to Patient Care
- According to the findings of this study, the efficacy of cysteine in the treatment of cases of organophosphate poisoning may depend 
on maintaining high therapeutic concentrations of cysteine.
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exposure to low and high concentrations of 2-PAM, 
L-cysteine and NAC separately in a water bath at 37 °C 
for 60 minutes. In total, 10 μL of the dichlorvos, 
2-PAM, NAC and cysteine solutions were added to 
1 mL of blood to produce final concentrations of 
0.21 μg.mL-1 (0.95 μmol.L-1), 149 μg.mL-1 (600 μmol.L-1), 
98 μg.mL-1 (600 μmol.L-1) and 72.7 μg.mL-1 
(600 μmol.L-1), representing the high doses of the 
drugs. An additional 5 μL of the 2-PAM, NAC and 
L-cysteine solutions were added to 1 mL of blood 
to produce final concentrations of 74.5 μg.mL-1
(300 μmol.L-1), 49 μg.mL-1 (300 μmol.L-1) and 
36.3 μg.mL-1 (300 μmol.L-1), representing the low 
doses of the drugs.
The plasma and red blood cells (RBCs) of each 
blood sample were then separated by centrifugation 
at 5,000 revolutions per minute for 10 minutes. Each 
plasma sample was diluted 100 times with distilled 
water and the diluted sample was used to determine 
BuChE activity. Each volume of the RBC sample was 
first washed three times with three volumes of normal 
saline and then haemolyzed and diluted 60 times with 
distilled water to sufficiently dilute thiol-containing 
(i.e. cysteine and NAC) and oxime-containing (i.e. 
2-PAM) compounds and prevent reactions with DTNB. 
The haemolyzed diluted sample (haemolysate) was 
used to determine AChE activity. Ellman’s kinetic 
method was used to determine the BuChE and AChE 
activities of diluted samples at 410 and 440 nm, 
respectively.18 
In order to measure BuChE activity, 50 μL of the 
diluted plasma sample was added to 150 μL of a reagent 
containing 0.423 mmol.L-1 of DTNB in 0.1 mol.L-1 of 
a phosphate buffer with a pH of 7.6 as well as 50 μL 
of substrate (10 mmol.L-1 of butyrylthiocholine iodide 
in distilled water) in each well of a 48-well plate and 
marked as a test well. All components of the test well 
were included in five blank wells, except for the sample 
which was replaced by an equivolume of normal saline. 
Initial and final absorbances of the test and blank wells 
were then recorded at 410 nm over a 5-minute period. 
Test well absorbances were subtracted from the average 
absorbance of the blank wells and divided by 0.0216 
as the product of the time period and the molar 
attenuation coefficient of the 5-thio-2-nitrobenzoate 
anion at 410 nm (0.0136 L.μmol-1.cm-1) and light path 
length (0.318 cm) and multiplied by the dilution factor 
(100 x 5 = 500). 
Subsequently, AChE activity was measured 
using 10 μL of the haemolysate sample added to 300 
μL of a reagent containing 0.27 mmol.L-1 of DTNB 
and 20 μmol.L-1 of quinidine sulfate in 0.1 mol.L-1 of 
a phosphate buffer at a pH of 7.6 and preincubated 
for 5 minutes at 37 °C. This procedure was followed 
by the addition of 10 μL of substrate (100 mmol.L-1 
of acetylthiocholine iodide in distilled water) in each 
well of a 48-well plate and marked as a test well. As 
before, five blank wells contained all components of 
the test well, except for the sample, which was replaced 
by an equivolume of normal saline. The initial and 
final absorbances of the test and blank wells were 
recorded during a 5-minute period at 440 nm. The 
absorbances of the test wells were subtracted from the 
average absorbance of the blank wells and divided by 
0.023 as the product of the time period and the molar 
attenuation coefficient of the 5-thio-2-nitrobenzoate 
anion at 440 nm (0.01434 L.μmol-1.cm-1) and light path 
length (0.32 cm) and multiplied by the dilution factor 
(60 x 32 = 1,920). The visible absorbances of samples 
were measured using a multi-mode microplate reader 
(Synergy™ HT Microplate Reader, BioTek Instruments 
Inc., Winooski, Vermont, USA). 
All BuChE and AChE activities were expressed 
in units per L (U.L-1). The activity of each sample 
was divided by that of the respective control (normal-
isation) and represented as a percentage. A one- 
sample t-test was used to analyse the statistical 
differences between the percentages of BuChE and 
AChE activities in the dichlorvos and control groups, 
for which the latter was deemed to have 100% ChE 
activity. Differences between percentages of BuChE 
and AChE activities in the experimental groups were 
analysed using a one-way analysis of variance test 
followed by a Scheffe post-hoc test. The Statistical 
Package for the Social Sciences (SPSS), Version 23.0 
(IBM Corp., Armonk, New York, USA) was used for all 
statistical analyses. A P value of <0.050 was considered 
statistically significant. Graphs were produced using 
SigmaPlot software, Version 12.0 (Systat Software Inc., 
San Jose, California, USA). 
This study was approved by the Ethics Committee 
of the Mazandaran University of Medical Sciences, 
Sari, Mazandaran, Iran (#1072). All procedures were 
performed in accordance with the ethical standards 
of the revised Declaration of Helsinki of 2008. All 
participants signed an informed consent form before 
being included in the study.
Results
Dichlorvos significantly reduced BuChE activity in 
comparison to the control group (37.8% ± 2.5%; 
P <0.010). Both low and high doses of 2-PAM (55.0% 
± 3.5% and 72.0% ± 3.4%, respectively) significantly 
increased BuChE activity in comparison to the 
dichlorvos group (P <0.010 and <0.001, respectively). 
Low concentrations of NAC and cysteine (38.8% ± 2.0% 
and 35.5% ± 2.7%, respectively) did not significantly 
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increase BuChE activity over dichlorvos (P >0.050 
each). A high dose of NAC (37.5% ± 1.7%) also did not 
significantly increase BuChE activity in comparison to 
dichlorvos (P >0.050). However, a high concentration 
of cysteine (53.8% ± 3.9%) significantly increased 
BuChE activity over that of dichlorvos (P <0.010). A 
high concentration of 2-PAM significantly increased 
BuChE activity in comparison to a low concentration 
(P <0.010). Moreover, a low dose of 2-PAM significantly 
increased BuChE activity in comparison to a low dose 
of cysteine (P <0.010) [Figure 1].
AChE activity was significantly reduced in 
the dichlorvos group compared to the control 
group (60.0% ± 2.5%; P <0.010), although to a lesser 
extent than for BuChE activity. Both low and high 
doses of 2-PAM (81.9% ± 2.4% and 94.6% ± 2.8%, 
respectively) significantly increased AChE activity 
over that of dichlorvos (P <0.010 each). Low and high 
concentrations of NAC (63.0% ± 2.0% and 67.1% ± 
4.7%, respectively) did not significantly increase AChE 
activity in comparison to dichlorvos (P >0.050 each). 
Low and high concentrations of cysteine (75.0% ± 
3.3% and 88.7% ± 3.4%, respectively) significantly 
increased AChE activity compared to the dichlorvos 
group (P <0.010 and <0.010, respectively). There was 
no significant difference between low and high con-
centrations of 2-PAM or low concentrations of 2-PAM 
and cysteine in terms of AChE activity (P >0.050 each). 
There was also no significant difference between high 
concentrations of 2-PAM and cysteine with regards 
to AChE activity. However, a high dose of 2-PAM 
significantly increased AChE activity over that of a low 
cysteine dose (P <0.010) [Figure 2].
Discussion
Previous research has indicated that NAC replenishes 
glutathione storage and has antioxidant and free 
radical scavenging properties.19 It is a prodrug which 
is enzymatically metabolised (i.e. deacetylated) by 
the liver into its active metabolite cysteine and serves 
as a cysteine donor.20 The thiol group of cysteine 
is reactive toward xenobiotics and seems to be 
responsible for its beneficial effects in poisoning 
cases.21 In the present study, the reactivation effect 
of equimolar concentrations of 2-PAM, NAC and 
cysteine on dichlorvos-induced BuChE and AChE 
inhibition was investigated. The results demonstrated 
that dichlorvos inhibited BuChE activity to a greater 
degree than AChE activity; this finding is in agreement 
with a statement by Jafari et al. indicating that AChE 
is less sensitive to OPs than BuChE.22 Ríos et al. have 
previously shown that while 2-PAM concentrations as 
low as 66 μmol.L-1 are sufficient to prevent deaths in 
most in vivo cases of OP poisoning, concentrations of 
up to 700 μmol.L-1 are much more effective.23 In the 
present study, samples were treated with both low 
(300 μmol.L-1) and high (600 μmol.L-1) concentrations 
of 2-PAM in order to compare ChE reactivation effects; 
the results showed that a high concentration of 2-PAM 
increased BuChE but not AChE activity in comparison 
to a low concentration. These findings confirm that 
ChE reactivation in OP poisoning is dependent on the 
plasma concentrations of 2-PAM.23
The concentrations of 2-PAM, NAC and cysteine 
in the current study were selected based on their 
therapeutic plasma concentrations in humans.23,24 The 
Figure 1: Chart showing mean plasma cholinesterase 
activity in different experimental groups as a measure of 
human cholinesterase reactivation in the treatment of 
organophosphide poisoning (N = 22). The dichlorvos 
group was compared with the control group while all 
other groups were compared with the dichlorvos group.
ChE = cholinesterase; DDVP = dichlorvos; 2-PAM = pralidoxime; 
NAC = N-acetylcysteine. 
*Statistically significant difference in comparison to the control 
group (P <0.010). †Statistically significant difference in comparison 
to the dichlorvos group (P <0.010). ‡Statistically significant 
difference in comparison to a low dose of cysteine (P <0.010). 
§Statistically significant difference in comparison to a low dose of 
2-PAM (P <0.010).
Figure 2: Chart showing mean red blood cell 
cholinesterase activity in different experimental groups 
as a measure of human cholinesterase reactivation in 
the treatment of organophosphide poisoning (N = 22). 
The dichlorvos group was compared with the control 
group while all other groups were compared with the 
dichlorvos group.
RBC = red blood cell; ChE = cholinesterase; DDVP = dichlorvos; 
2-PAM = pralidoxime; NAC = N-acetylcysteine.
*Statistically significant difference in comparison to the control 
group (P <0.010). †Statistically significant difference in comparison 
to the dichlorvos group (P <0.010). ‡Statistically significant 
difference in comparison to a low dose of cysteine (P <0.010).
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standard intravenous regimen of NAC—150 mg/kg-1 
for 15 minutes followed by 50 mg/kg-1 for four hours 
and 100 mg/kg-1 over the next 16 hours—produces 
initial NAC plasma concentrations ranging from 
304–875 μg.mL-1.24 Concentrations subsequently fall 
rapidly and reach a relatively constant level of approx-
imately 35 μg.mL-1 after 12 hours until the infusion is 
stopped.24 In comparison to dichlorvos, concentrations of 
NAC in the present study did not significantly increase 
BuChE and AChE activities; however, both BuChE and 
AChE activities significantly increased with concen- 
trations of cysteine. This finding indicates that cysteine, 
the active metabolite of NAC, is responsible for the 
reactivation of ChEs. The absence of a metabolising 
organ—the liver—in the present in vitro study 
may explain why NAC did not elevate BuChE and 
AChE activities in comparison to cysteine.20 Thus, 
in clinical situations in which liver function is normal, 
NAC treatment may still be effective. The results of 
the present work indicate that therapeutic plasma 
concentrations of cysteine (or, potentially, NAC) for 
the treatment of OP poisoning strongly depends on 
OP plasma concentrations. 
The pKa of nucleophiles has been shown to play 
an important role in their reaction with OPs, in that 
more basic nucleophiles with higher pKa values show a 
lower reactivity.2,25 The pKa values of the 2-PAM oxime 
and cysteine thiol groups are 7.8 and 8.3, respectively, 
which reflect a favourable range.2,26 In addition, accor-
ding to the Henderson-Hasselbalch equation, the 
2-PAM oxime and cysteine thiol groups are 28.48% 
and 11.18% ionised at a pH of 7.4, respectively.2 Thus, 
it is expected that, in addition to 2-PAM, cysteine 
could also react with the OP-ChE complex and 
displace OP with a nucleophilic attack, resulting in 
the reactivation of ChEs. With a pKa of 9.5, NAC is 
less reactive to nucleophiles than cysteine.27 For a 
nucleophilic attack of the cysteine thiol group to the 
phosphorus-oxygen bond of the OP-ChE complex, the 
phosphorus-oxygen bond between the serine hydroxyl 
oxygen atom from ChE and the phosphorous atom 
of OP should be cleaved and a phosphorus-sulfur 
bond formed between the cysteine thiol sulfur atom 
and the phosphorus atom of OP. Cysteine is a weak 
nucleophile and the phosphorus-sulfur bond is much 
weaker than a phosphorus-oxygen bond and therefore 
easier to break; however, the concentration of the 
reactants, namely cysteine and OP, seems to play a 
critical role in this reaction.28,29 On the basis of collision 
theory, a higher concentration of reactants increases 
the probability of effective collisions, consequently 
resulting in the formation of a product.30 However, 
to be effective, collisions should occur in a particular 
molecular orientation.
In the present study, concentrations of dichlorvos 
and cysteine were 0.95 μmol.L-1 and 300 μmol.L-1 
(low dose) and 600 μmol.L-1 (high dose), respectively. 
In clinical cases of OP poisoning, the plasma concen-
tration of OP is very high due to the high intake.31 
Thus, large amounts of NAC and even 2-PAM should 
be administered intravenously to be effective. Some 
researchers have reported that although intravenous 
NAC reduced hospitalisation time among OP-
poisoned individuals, it unfortunately did not increase 
ChE activity.11 One explanation for this outcome may 
be related to the low plasma concentration of NAC 
in comparison to the high plasma concentration of 
OP. Another explanation may be related to the direct 
reaction of NAC—or, more accurately, cysteine-with 
OPs which results in more polar and may be more 
excretable product.2 A similar result has been observed 
with the administration of 2-PAM to OP-poisoned 
individuals, in that ChE reactivation seems to depend 
on the plasma concentrations of 2-PAM and OP, 
with high concentrations of 2-PAM necessary for 
the adequate reactivation of OP-inhibited human RBC 
ChEs.23 This phenomenon explains why oximes are not 
always useful in the management of OP poisoning.6–8
Figure 3 illustrates the proposed mechanism 
of nucleophilic attack of 2-PAM and cysteine to 
dichlorvos, in which the reactions of 2-PAM and 
cysteine with dichlorvos proceed through an associative 
stepwise addition-elimination mechanism.2 In both 
of these reactions, the 2,2-dichlorovinylate anion (as 
a leaving group) is separated from a pentacoordinate 
phosphorene intermediate and leaves a polar product 
which seems to be more excretable than dichlorvos. 
The 2,2-dichlorovinylate anion then gains a hydrogen 
ion and is converted to 2,2-dichlorovinyl alcohol which 
in turn undergoes a spontaneous rearrangement and 
is converted to dichloroacetaldehyde, a metabolite of 
dichlorvos.2 One of the detoxification mechanisms of 
NAC in acetaminophen poisoning is its direct reaction 
with N-acetyl-p-benzoquinone imine, the toxic meta- 
bolite of acetaminophen.19 Thus, NAC may still act 
as an antidote in OP poisoning due to its direct 
reaction and neutralisation properties. On this basis, 
Figure 4 depicts another proposed mechanism for 
the reactivation of OP-inhibited ChEs by 2-PAM and 
cysteine wherein the reactions of 2-PAM and cysteine 
with OP-inhibited ChEs also proceed via an associative 
stepwise addition-elimination process. Similarly, the 
serine anion of ChE as a leaving group is separated 
from a pentacoordinate phosphorane intermediate in 
both of these reactions.
The pKa of the leaving group has also been shown 
to play an important role in the reaction of nucleophiles, 
as more acidic leaving groups with low pKa values are 
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Figure 3: Diagram showing a proposed nucleophilic mechanism for the reaction of (A) pralidoxime and 
(B) N-acetylcysteine with dichlorvos.
CH3/H3C = methyl group; N = nitrogen; OH = hydroxide; H = hydrogen; Cl = chlorine; O = oxygen; P = phosphorus; DDVP = dichlorvos; 
NH2 = amine group; S = sulfur.
Figure 3A reproduced with permission from Shetab-Boushehri SV, Shetab-Boushehri SF, Abdollahi M. Possible role of Mg2+ ion in the reaction of 
organophosphate (dichlorvos) with serine.2
Figure 4: Diagram showing a proposed nucleophilic mechanism for the reaction of (A) pralidoxime and 
(B) N-acetylcysteine with the dichlorvos-cholinesterase complex. For simplification, only the serine moiety of 
cholinesterase is shown.
CH3/H3C = methyl group; N = nitrogen; OH = hydroxide; H = hydrogen; O = oxygen; NH2 = amine group; P = phosphorus; 
OP = organophosphate; S = sulfur; HN = amine; SH = thiol; H2O = water.
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more easily separated from OPs.25 This could explain 
why certain OPs more rapidly age ChEs in comparison 
to others.5 In the current study, the displacement 
of serine as a leaving group with a pKa of 13.0 by 
2-PAM and cysteine as nucleophiles with pKas of 
7.8 and 8.3, respectively, seems thermodynamically 
unfavourable;2,26 nevertheless, clinical evidence as well 
as the results of the present study show that although 
2-PAM has a lower pKa than serine, it displaces the 
serine moiety in the OP-ChE complex which results 
in reactivated ChEs.3,4,8,9 Cysteine, although a weaker 
nucleophile, seems to follow this mechanism but 
at much higher plasma concentrations. As in the 
case of direct reactions of 2-PAM and cysteine with 
dichlorvos, the displacement of the serine moiety of 
the OP-AChE complex by 2-PAM and cysteine seems 
to be dose-dependent. Although cysteine is a weak 
nucleophile, the current study demonstrates that it 
nevertheless displaces the serine moiety in the OP-
ChE complex at high concentrations. 
The authors suggest the administration of a 
maximum tolerable intravenous dose of NAC for the 
treatment of OP poisoning; however, extensive animal 
studies are needed to confirm this suggestion and 
NAC should be considered a supportive antidote until 
the safety and efficacy of this approach is approved. 
Considering its potential for metabolising into 
cysteine, NAC could be an alternative therapeutic 
agent in OP poisoning. A comparative animal study 
on the beneficial effects of NAC and cysteine on the 
reactivation of ChEs in OP poisoning is therefore 
proposed for future research. 
Conclusion
The results of the present study suggest that the direct 
reactions of 2-PAM and cysteine with dichlorvos, 
and the subsequent reactivation of phosphorylated 
ChEs, proceed through an associative stepwise 
addition-elimination process. In addition, the findings 
indicate that cysteine directly reacts with OPs at low 
concentrations while, at very high concentrations, it 
replaces serine in the pentacoordinate intermediate 
and regenerates inhibited ChEs as well as directly 
reacting with dichlorvos. Moreover, it is possible that 
higher doses of NAC in a clinical context may also have 
the same effect; however, further studies are required 
to confirm this theory.
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